Prime Therapeutics Urges Caution On Mandates Of Abuse-Deterrent Formulations Of Opioids Citing Value Concerns Post author:Sam Post published:July 20, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like ImmunoGen Announces Conference Call To Discuss Its Second Quarter 2017 Financial Results July 13, 2017 EnteroMedics Announces Proposed Underwritten Public Offering August 10, 2017 Mirati Therapeutics Reports Second Quarter 2017 Financial Results August 3, 2017
ImmunoGen Announces Conference Call To Discuss Its Second Quarter 2017 Financial Results July 13, 2017